More on AEMD
Data
Financials
Upcoming Events
News
Click line-items for a historical chart and %
| REVENUES | |
| Grant income | |
| Subcontract income | |
| Sale of research and development | |
| [Revenues] | |
| OPERATING EXPENSES | |
| Professional fees | 510.98K |
| Payroll and related | 1.81M |
| General and administrative | 290.13K |
| Impairment | |
| Total operating expenses | 2.61M |
| OPERATING LOSS | -2.23M |
| OTHER EXPENSE (INCOME) | |
| Loss on extinguishment of debt | 0 |
| Loss on settlement of accrued interest and damages | |
| Gain on change in fair value of derivative liability | |
| Interest and other debt expenses | 36.58K |
| Interest income | |
| Other | |
| Total other expenses | |
| NET LOSS | -2.26M |
| BASIC AND DILUTED LOSS PER COMMON SHARE (in Dollars per share) | -0.29 |
| WEIGHTED AVERAGE NUMBER OF COMMON SHARES OUTSTANDING – BASIC AND DILUTED (in Shares) | |
Entities mentioned with AEMD
- FDA | View Related Stories »
- Twitter | View Related Stories »
- Earnings | View Related Stories »
- 13G | View Related Stories »
- H.C. Wainwright | View Related Stories »
- S1 | View Related Stories »
- S3 | View Related Stories »
- Pre Market Movers | View Related Stories »
- Show More...
